Personal Story
Catherine’s Personal Story: Severe Gastroparesis I was just diagnosed with Gastroparesis about two weeks ago, I can not hold down solid foods for long. i finally got in to see the gi doctor and he sent me to take a gastric emptying study done and it said that i have a sever case of gastroparesis. […]
Personal Story
Problems started around 10 yrs. old with very bad gasteral pains on rare occasions until 19 then was in car accident and 6 months later had exploratory surgery for torn entestine and hernia and removed appendix while they were already in there. Had 2 inches below stomach removed doc said I would be on Rolaids […]
DDH Chat
Gastroparesis Advocate, Patient Education and Advocacy Specialist with the Association of Gastrointestinal Motility Disorders (AGMD), and IFFGD Patient Advisory Committee member, Melissa Adams VanHouten, talks about amplifying the voice of the gastroparesis community during Gastroparesis Awareness Month in August through a grassroots campaign to establish official proclamations in cities and states across the nation. Gastroparesis, […]
Testimony
The following written comments were submitted to the Office of Disability Policy of the Social Security Administration (SSA) by IFFGD President, Ceciel T. Rooker, in response to Docket No. SSA-2017-0042 on September 23, 2019. Thank you for your leadership at the Office of Disability Policy. The International Foundation for Gastrointestinal Disorders (IFFGD) is grateful for the […]
Testimony
The following written comments were submitted to the Dockets Management Staff (HFA-305) Food and Drug Administration by IFFGD President, Ceciel T. Rooker, in response to Docket No. FDA-2019-D-4247 on December 30, 2019. Thank you for your leadership at the Center for Drug Evaluation and Research in the Food and Drug Administration (FDA). The International Foundation for […]
Testimony
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 17, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee to discuss approval of prucalopride: The International Foundation for Gastrointestinal Disorders (IFFGD) commends the FDA on its commitment to […]
Testimony
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Department of Defense (DoD) in connection with a January 10, 2019 meeting of the TRICARE Beneficiary Advisory Panel (BAP) regarding the Uniform Formulary and, specifically, review of gastrointestinal agents: The International Foundation for Gastrointestinal Disorders (IFFGD) commends TRICARE and the […]
Testimony
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with an October 16, 2012 meeting of the Gastrointestinal Drugs Advisory Committee to consider the new drug application (NDA) 203441 by NPS Pharmaceuticals for the drug with the proposed trade name GATTEX® (teduglutide) for the treatment of adult patients with […]
Testimony
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with a January 11, 2012 meeting of the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee to consider the premarket approval of the LINX Reflux Management System for the treatment of gastroesophageal reflux disease (GERD): On behalf […]
News Article
MOUNT PLEASANT, S.C., Dec. 1, 2025 /PRNewswire/ — This December for Constipation Awareness Month, IFFGD is shedding a light on common causes, prevention, and treatments. As well as promoting healthy conversations and lifestyle habits to support bowel movements. Constipation affects millions, approximately 1 out of every 6-7 people worldwide and annually leading to more than 1.5 million […]
Testimony
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 18, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee and Risk Management Advisory Committee to discuss the reintroduction of Zelnorm: The International Foundation for Gastrointestinal Disorders (IFFGD) […]
Testimony
IFFGD President, Ceciel Rooker, submitted the following written statement to the House and Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding Fiscal Year (FY) 2020 appropriations for medical research and public health programs. April 9, 2019 STATEMENT OF CECIEL T. ROOKER PRESIDENT INTERNATIONAL FOUNDATION FOR […]